Market Overview

PTC Therapeutics to Participate at Upcoming Investor Conferences

Share:

SOUTH PLAINFIELD, N.J., May 5, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ:PTCT) today announced that management will present in a virtual format at the following conferences:

2020 BofA Securities Health Care Conference
Tuesday, May 12th at 3:40 p.m. ET

2020 RBC Capital Markets Global Healthcare Conference
Wednesday, May 20th at 8:35 a.m. ET

The presentations will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.

 

FOR MORE INFORMATION PLEASE CONTACT:

Media:       

Investors:

Jane Baj      

Alex Kane

+1 (908) 912-9167    

+1 (908) 912-9643

jbaj@ptcbio.com       

akane@ptcbio.com  

 

Cision View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-301052401.html

SOURCE PTC Therapeutics, Inc.

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com